August 12, 2025 – OptoSeeker Biotech (Shenzhen) Co., Ltd. (hereinafter referred to as OptoSeeker Biotech) and MGI have announced a strategic partnership. This collaboration will leverage both parties' technological and platform strengths in the life sciences to jointly create an antibody discovery platform covering the entire workflow of "screening-sequencing-data analysis," accelerating the industrialization of life science instruments.

Recently, Optoseeker Biotech welcomed a visit from Professor Huabing Yin of the School of Engineering at the University of Glasgow. Professor Yin's visit brought a leading-edge international scientific perspective and opportunities for collaboration to Optoseeker Biotech, as both parties engaged in in-depth discussions on digital microfluidics and single-cell analysis technology.

Optoseeker Biotech, an innovator in advanced life science instrumentation, and BioMap, a pioneer in life science AI, today announced a strategic collaboration set to dramatically accelerate the development of novel antibody therapeutics

OptoSeeker Secures Tens of Millions in Angel+ Round Funding

Shenzhen Biomedical Alliance Induction & Wuhan Partner Summit Success​

The 2025 Western China (Chengdu) Biopharmaceutical and Technology Equipment Exhibition concluded successfully at the Western International Expo City.